Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
New words:
abandonment, adult, Britain, broader, COLUMVI, complaint, consulting, deprioritization, DMCC, durability, England, exited, Fit, genetic, Great, headcount, idiopathic, imaging, LUMA, MHRA, Moderate, optimization, partly, pediatric, refocusing, registry, reinvested, schizophrenia, situation, UK, unforeseen, YTD
Removed:
assignment, ATV, Bruton, case, cease, ceased, challenge, Committee, delivered, derecognized, dispute, diversion, Durham, effort, emerge, enabled, EPO, expression, finger, Germany, hospital, identified, infected, InnoCare, kinase, leveraging, modification, modulate, negotiation, neuromuscular, orelabrutinib, PDUFA, proceeding, protein, reserve, scheduled, selected, site, slowdown, TBA, travel, tyrosine, withdraw, zinc
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view